Riik: Lõuna-Aafrika Vabariik
keel: inglise
Allikas: South African Health Products Regulatory Authority (SAHPRA)
Knoll
INDICATIONS [/za_1125.html#1] [/za_1125.html#1] [/za_1125.html#1] CONTRA-INDICATIONS [/za_1125.html#1] [/za_1125.html#1] DOSAGE [/za_1125.html#1] [/za_1125.html#1] SIDE-EFFECTS [/za_1125.html#1] [/za_1125.html#1] [/za_1125.html#1] PREGNANCY [/za_1125.html#1] [/za_1125.html#1] OVERDOSE [/za_1125.html#1] IDENTIFICATION [/za_1125.html#1] [/za_1125.html#1] PATIENT INFORMATION FROBEN 50 : TABLETS FROBEN 100 : TABLETS FROBEN : SUPPOSITORIES SCHEDULING STATUS Schedule 3 PROPRIETARY NAME (and dosage form) FROBEN 50 : TABLETS FROBEN 100 : TABLETS FROBEN : SUPPOSITORIES COMPOSITION Tablets 50 mg : Each sugar coated tablet contains 50 mg FLURBIPROFEN 100 mg : Each sugar coated tablet contains 100 mg flurbiprofen Suppositories : Each suppository contains 100 mg flurbiprofen PHARMACOLOGICAL CLASSIFICATION A3.1/Antirheumatic (anti-inflammatory agent). PHARMACOLOGICAL ACTION FROBEN, chemically described as 2-(2-fluoro-4-biphenylyl) propionic acid, is a non-steroidal anti-inflammatory agent which has significant anti-inflammatory, analgesic and antipyretic properties. FROBEN is an inhibitor of prostaglandin synthetase enzymes which are known to be associated with inflammation, pain and fever. INDICATIONS FROBEN is indicated in the treatment of rheumatoid arthritis, osteo-arthritis and ankylosing spondylitis. FROBEN is also indicated for the relief of pain following soft tissue trauma, dental surgery, dysmenorrhoea, post episiotomy pain and post partum pain. CONTRA-INDICATIONS FROBEN should not be given to patients with peptic ulceration. The safety of FROBEN during pregnancy or lactation has not been established. FROBEN should be prescribed with caution for those patients with asthma, and especially for patients who have developed bronchospasm with other non-steroidal agents. Should no Lugege kogu dokumenti